Tau protein aggregation inhibitor
We would like to introduce an invention that can suppress the aggregation of tau proteins.
Various therapeutic agents have been developed for neurodegenerative diseases up to now, but all of those actually used in treatment are symptomatic therapies, and no successful development of curative drugs has been achieved. The purpose of this invention is to provide a agent that suppresses the aggregation of tau protein, which is a cause of Alzheimer's disease and frontotemporal dementia. By suppressing the aggregation of tau protein, it becomes possible to prevent or treat neurodegenerative diseases caused by the aggregation of tau protein. [Research Overview] - Creation of a tau protein aggregation suppressor with phorbol esters as the active ingredient - It is preferable that the phorbol ester is phorbol 12-myristate 13-acetate - Capable of suppressing the aggregation of tau protein - Capable of preventing or treating neurodegenerative diseases *For more details, please refer to the PDF document or feel free to contact us.
- Company：山口ティー・エル・オー
- Price：Other
